TWO SIGMA ADVISERS, LP - GENMARK DIAGNOSTICS INC ownership

GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 98 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of GENMARK DIAGNOSTICS INC
ValueSharesWeighting
Q1 2021$1,747,000
-49.9%
73,100
-69.4%
0.01%
-44.4%
Q4 2020$3,489,000
-59.7%
239,000
-60.8%
0.01%
-64.0%
Q3 2020$8,652,000
+124.5%
609,300
+132.6%
0.02%
+127.3%
Q2 2020$3,854,000
+334.5%
262,000
+21.7%
0.01%
+266.7%
Q1 2020$887,000
-30.1%
215,300
-18.4%
0.00%0.0%
Q4 2019$1,269,000
-17.3%
263,900
+4.3%
0.00%
-25.0%
Q3 2019$1,534,000
+0.7%
253,100
+7.9%
0.00%0.0%
Q2 2019$1,523,000
-1.0%
234,600
+8.2%
0.00%0.0%
Q1 2019$1,538,000
+119.1%
216,900
+50.2%
0.00%
+100.0%
Q4 2018$702,000
-36.8%
144,400
-4.4%
0.00%
-33.3%
Q3 2018$1,111,000
+19.5%
151,100
+3.7%
0.00%0.0%
Q2 2018$930,000
+47.6%
145,700
+25.7%
0.00%
+50.0%
Q1 2018$630,000
+1.9%
115,900
-21.8%
0.00%0.0%
Q4 2017$618,000
+15.3%
148,300
+254.8%
0.00%0.0%
Q1 2017$536,000
+1.3%
41,800
-3.2%
0.00%0.0%
Q4 2016$529,000
-26.1%
43,200
-28.8%
0.00%
-33.3%
Q3 2016$716,000
+80.8%
60,700
+38.9%
0.00%0.0%
Q2 2015$396,000
-28.9%
43,700
+1.9%
0.00%
-25.0%
Q1 2015$557,000
-30.0%
42,900
-26.7%
0.00%
-33.3%
Q4 2014$796,000
+460.6%
58,500
+457.1%
0.01%
+500.0%
Q2 2014$142,00010,5000.00%
Other shareholders
GENMARK DIAGNOSTICS INC shareholders Q1 2018
NameSharesValueWeighting ↓
Casdin Capital, LLC 3,500,000$25,725,0003.13%
CADIAN CAPITAL MANAGEMENT, LP 3,830,399$28,153,0001.28%
Mesirow Financial Investment Management, Inc. 33,001$243,0001.25%
Bellevue Group AG 1,339,502$9,845,0000.62%
NEEDHAM INVESTMENT MANAGEMENT LLC 260,000$1,912,0000.58%
Lyon Street Capital, LLC 109,850$807,0000.50%
Private Wealth Partners, LLC 300,000$2,205,0000.34%
Penn Capital Management Company, LLC 455,064$3,345,0000.25%
HighTower Advisors, LLC 2,337,132$17,179,0000.12%
Schonfeld Strategic Advisors LLC 376,000$2,763,0000.12%
View complete list of GENMARK DIAGNOSTICS INC shareholders